Swenerton K - Search Results

1

A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184.

Mackay HJ, Tinker A, Winquist E, Thomas G, Swenerton K, Oza A, Sederias J, Ivy P, Eisenhauer EA. Mackay HJ, et al. Among authors: swenerton k. Gynecol Oncol. 2010 Feb;116(2):163-7. doi: 10.1016/j.ygyno.2009.08.012. Epub 2009 Sep 8. Gynecol Oncol. 2010. PMID: 19740535 Clinical Trial.

2

Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116).

Oza AM, Elit L, Swenerton K, Faught W, Ghatage P, Carey M, McIntosh L, Dorr A, Holmlund JT, Eisenhauer E; NCIC Clinical Trials Group Study (NCIC IND.116). Oza AM, et al. Among authors: swenerton k. Gynecol Oncol. 2003 Apr;89(1):129-33. doi: 10.1016/s0090-8258(02)00144-0. Gynecol Oncol. 2003. PMID: 12694666 Clinical Trial.

3

A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149).

Hirte H, Oza A, Swenerton K, Ellard SL, Grimshaw R, Fisher B, Tsao M, Seymour L. Hirte H, et al. Among authors: swenerton k. Gynecol Oncol. 2010 Sep;118(3):308-12. doi: 10.1016/j.ygyno.2010.05.005. Epub 2010 Jun 19. Gynecol Oncol. 2010. PMID: 20646751 Clinical Trial.

4

Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study.

Gelmon KA, Tischkowitz M, Mackay H, Swenerton K, Robidoux A, Tonkin K, Hirte H, Huntsman D, Clemons M, Gilks B, Yerushalmi R, Macpherson E, Carmichael J, Oza A. Gelmon KA, et al. Among authors: swenerton k. Lancet Oncol. 2011 Sep;12(9):852-61. doi: 10.1016/S1470-2045(11)70214-5. Epub 2011 Aug 19. Lancet Oncol. 2011. PMID: 21862407 Clinical Trial.

5

Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience.

Hoskins PJ, Le N, Ellard S, Lee U, Martin LA, Swenerton KD, Tinker AV; British Columbia Cancer Agency. Hoskins PJ, et al. Gynecol Oncol. 2008 Jan;108(1):58-62. doi: 10.1016/j.ygyno.2007.08.084. Epub 2007 Oct 23. Gynecol Oncol. 2008. PMID: 17935761

6

Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience.

Tinker AV, Bhagat K, Swenerton KD, Hoskins PJ. Tinker AV, et al. Among authors: swenerton kd. Gynecol Oncol. 2005 Jul;98(1):54-8. doi: 10.1016/j.ygyno.2005.03.037. Gynecol Oncol. 2005. PMID: 15904950

7

Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma.

Al-Barrak J, Santos JL, Tinker A, Hoskins P, Gilks CB, Lau H, Swenerton KD. Al-Barrak J, et al. Among authors: swenerton kd. Gynecol Oncol. 2011 Jul;122(1):107-10. doi: 10.1016/j.ygyno.2011.03.011. Epub 2011 Apr 3. Gynecol Oncol. 2011. PMID: 21463887

8

Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies.

Lê LH, Swenerton KD, Elit L, Provencher DM, Stuart GC, LE T, Lee U, Rodgers A, Pond GR, Hu H, Oza AM. Lê LH, et al. Among authors: swenerton kd. Int J Gynecol Cancer. 2005 Sep-Oct;15(5):799-806. doi: 10.1111/j.1525-1438.2005.00139.x. Int J Gynecol Cancer. 2005. PMID: 16174227 Free article. Clinical Trial.

9

Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation.

Hoskins PJ, Le N, Gilks B, Tinker A, Santos J, Wong F, Swenerton KD. Hoskins PJ, et al. J Clin Oncol. 2012 May 10;30(14):1656-62. doi: 10.1200/JCO.2011.40.1646. Epub 2012 Apr 9. J Clin Oncol. 2012. PMID: 22493415

10

Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: a trial of the national cancer institute of Canada clinical trials group.

Dark GG, Calvert AH, Grimshaw R, Poole C, Swenerton K, Kaye S, Coleman R, Jayson G, Le T, Ellard S, Trudeau M, Vasey P, Hamilton M, Cameron T, Barrett E, Walsh W, McIntosh L, Eisenhauer EA. Dark GG, et al. Among authors: swenerton k. J Clin Oncol. 2005 Mar 20;23(9):1859-66. doi: 10.1200/JCO.2005.02.028. Epub 2005 Feb 7. J Clin Oncol. 2005. PMID: 15699482 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters